Zeitschriftenartikel zum Thema „Generation of negative triples“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Generation of negative triples" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Vallée-Tourangeau, Frédéric, Neville G. Austin und Sandra Rankin. „Inducing a Rule in Wason's 2–4–6 Task: A Test of the Information-Quantity and Goal-Complementarity Hypotheses“. Quarterly Journal of Experimental Psychology Section A 48, Nr. 4 (November 1995): 895–914. http://dx.doi.org/10.1080/14640749508401422.
Der volle Inhalt der QuelleVallée-Tourangeau, Frédéric. „Utilities in the 2-4-6 Task“. Experimental Psychology 59, Nr. 5 (01.05.2012): 265–71. http://dx.doi.org/10.1027/1618-3169/a000152.
Der volle Inhalt der QuelleWang, Liuquan. „Arithmetic identities and congruences for partition triples with 3-cores“. International Journal of Number Theory 12, Nr. 04 (10.04.2016): 995–1010. http://dx.doi.org/10.1142/s1793042116500627.
Der volle Inhalt der QuelleTierno, Domenico, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati und Bruna Scaggiante. „Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications“. International Journal of Molecular Sciences 24, Nr. 11 (02.06.2023): 9688. http://dx.doi.org/10.3390/ijms24119688.
Der volle Inhalt der QuelleWu, Jiande, Tarun K. K. Mamidi, Lu Zhang und Chindo Hicks. „Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer“. International Journal of Genomics 2020 (07.07.2020): 1–16. http://dx.doi.org/10.1155/2020/2641370.
Der volle Inhalt der QuelleLin, Po‐Han, Ming Chen, Li‐Wei Tsai, Chiao Lo, Tzu‐Chun Yen, Thomas Yoyan Huang, Chih‐Kai Chen, Sheng‐Chih Fan, Sung‐Hsin Kuo und Chiun‐Sheng Huang. „Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer“. Cancer Science 111, Nr. 4 (19.02.2020): 1375–84. http://dx.doi.org/10.1111/cas.14313.
Der volle Inhalt der QuelleWu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang und Chindo Hicks. „Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer“. Cancers 12, Nr. 6 (12.06.2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Der volle Inhalt der QuelleRaftery, Martin J., Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer und Gabriele Pecher. „Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer“. International Journal of Molecular Sciences 24, Nr. 10 (20.05.2023): 9038. http://dx.doi.org/10.3390/ijms24109038.
Der volle Inhalt der QuelleZhang, Zhenghang, Jinlu Jia, Yalin Wan, Yang Zhou, Yuting Kong, Yurong Qian und Jun Long. „TransR*: Representation learning model by flexible translation and relation matrix projection“. Journal of Intelligent & Fuzzy Systems 40, Nr. 5 (22.04.2021): 10251–59. http://dx.doi.org/10.3233/jifs-202177.
Der volle Inhalt der QuelleBen-Baruch, Noa, Tamar Peretz-Yablonski, Georgeta Fried, Moshe J. Inbar, Yousef Samih, Victoria Neiman, Bella Nisenbaum et al. „Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel.“ Journal of Clinical Oncology 32, Nr. 15_suppl (20.05.2014): 1028. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.1028.
Der volle Inhalt der QuelleThouvenot, B., S. Verdun, J. Tomasina, B. Hilselberger, M. Brulliard, L. Bonnard, M. Trarbach, J. Armand, V. Ogier und B. E. Bihain. „P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer“. Breast 24 (März 2015): S120. http://dx.doi.org/10.1016/s0960-9776(15)70304-8.
Der volle Inhalt der QuelleElsayed, Islam, und Yoshiki Nishi. „A Feasibility Study on Power Generation from Solar Thermal Wind Tower: Inclusive Impact Assessment Concerning Environmental and Economic Costs“. Energies 11, Nr. 11 (16.11.2018): 3181. http://dx.doi.org/10.3390/en11113181.
Der volle Inhalt der QuelleCaiazza, Francesco, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O’Donovan, John Crown und Michael J. Duffy. „Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells“. Endocrine-Related Cancer 23, Nr. 4 (April 2016): 323–34. http://dx.doi.org/10.1530/erc-16-0068.
Der volle Inhalt der QuelleLips, Esther H., Magali Michaut, Lennart Mulder, Nicolle Besselink, Marlous L. Hoogstraat, Marco J. Koudijs, Emile E. Voest et al. „Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC).“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 1010. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1010.
Der volle Inhalt der QuelleHu, Zhiwei, Rulong Shen, Amanda Campbell, Elizabeth McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu und William E. Carson. „Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON“. Cancer Immunology Research 6, Nr. 6 (05.04.2018): 671–84. http://dx.doi.org/10.1158/2326-6066.cir-17-0343.
Der volle Inhalt der QuelleWang, Wei, Hao Chen, Yang Xie, Sayantap Datta, Wei Li und Ruiwen Zhang. „Abstract 678: Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 678. http://dx.doi.org/10.1158/1538-7445.am2024-678.
Der volle Inhalt der QuelleDenu, Ryan A., Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour et al. „Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors“. Cancers 16, Nr. 9 (27.04.2024): 1707. http://dx.doi.org/10.3390/cancers16091707.
Der volle Inhalt der QuelleKareev, Yaakov, Naftali Halberstadt und Dorit Shafir. „Improving Performance and Increasing the Use of Non-Positive Testing in a Rule-Discovery Task“. Quarterly Journal of Experimental Psychology Section A 46, Nr. 4 (November 1993): 729–42. http://dx.doi.org/10.1080/14640749308401036.
Der volle Inhalt der QuelleHossain, Fokhrul, Samarpan Majumder, Justin David und Lucio Miele. „Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions“. Cancers 13, Nr. 15 (26.07.2021): 3739. http://dx.doi.org/10.3390/cancers13153739.
Der volle Inhalt der QuelleAlewine, Christine, Laiman Xiang, Takao Yamori, Gerhard Niederfellner, Klaus Bosslet und Ira Pastan. „Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers“. Molecular Cancer Therapeutics 13, Nr. 11 (19.09.2014): 2653–61. http://dx.doi.org/10.1158/1535-7163.mct-14-0132.
Der volle Inhalt der QuelleZhu, X., J. Bayani, M. Dewan, H. Tovey, L. Kilburn, K. Taylor, J. Banerji et al. „307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline“. Annals of Oncology 34 (Oktober 2023): S306—S307. http://dx.doi.org/10.1016/j.annonc.2023.09.503.
Der volle Inhalt der QuelleBhattarai, Shristi, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong und Ritu Aneja. „Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning“. Diagnostics 14, Nr. 1 (28.12.2023): 74. http://dx.doi.org/10.3390/diagnostics14010074.
Der volle Inhalt der QuelleKhandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz und Lauren S. Gollahon. „Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer“. Antioxidants 9, Nr. 2 (05.02.2020): 138. http://dx.doi.org/10.3390/antiox9020138.
Der volle Inhalt der QuellePircher, Magdalena, Thomas Winder und Andreas Trojan. „Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome“. Case Reports in Oncology 14, Nr. 1 (29.03.2021): 616–21. http://dx.doi.org/10.1159/000513905.
Der volle Inhalt der QuelleHerrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre und Eva Ciruelos Gil. „Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features“. Breast Care 15, Nr. 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Der volle Inhalt der QuelleDesa, Danielle E., Wencheng Wu, Robert M. Brown, Edward B. Brown, Robert L. Hill, Bradley M. Turner und Edward B. Brown. „Second-Harmonic Generation Imaging Reveals Changes in Breast Tumor Collagen Induced by Neoadjuvant Chemotherapy“. Cancers 14, Nr. 4 (09.02.2022): 857. http://dx.doi.org/10.3390/cancers14040857.
Der volle Inhalt der QuelleYang, Biyao, Rui Sang, Yi Li, Ewa Goldys und Wei Deng. „Abstract 5743: Liposome platform enables X-ray induced photodynamic therapy treatment against human triple negative breast cancer cells“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 5743. http://dx.doi.org/10.1158/1538-7445.am2024-5743.
Der volle Inhalt der QuelleNagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura et al. „Comprehensive genomic sequencing for triple negative breast cancer in Japan.“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Der volle Inhalt der QuelleAshourpour, Maryam, Fatemeh Mostafavi Hosseini, Mohsen Amini, Ebrahim Saeedian Moghadam, Faranak Kazerouni, Seyed Yousef Arman und Zahra Shahsavari. „Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468“. Asian Pacific Journal of Cancer Prevention 22, Nr. 7 (01.07.2021): 2079–87. http://dx.doi.org/10.31557/apjcp.2021.22.7.2079.
Der volle Inhalt der QuelleWeisman, Paul S., Charlotte K. Y. Ng, Edi Brogi, Rachel E. Eisenberg, Helen H. Won, Salvatore Piscuoglio, Maria R. De Filippo et al. „Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology“. Modern Pathology 29, Nr. 5 (04.03.2016): 476–88. http://dx.doi.org/10.1038/modpathol.2016.39.
Der volle Inhalt der QuelleSangiorgio, Valentina, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga und Elena Maria Elli. „P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES“. HemaSphere 7 (August 2023): e7820571. http://dx.doi.org/10.1097/01.hs9.0000971120.78205.71.
Der volle Inhalt der QuelleBerisha, Eranda, Maria del Carmen Chacon Castro, Adnin Ashrafi, Narges Salamat, Parinaz Sadat Alemi und Li Zhang. „Abstract 4942: Heme targeting and its mechanistic role in triple-negative breast cancer suppression“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 4942. http://dx.doi.org/10.1158/1538-7445.am2023-4942.
Der volle Inhalt der QuelleYun, Jiwon, Jung-Ah Kim, Byungjin Hwang, Hee Sue Park, Kyongok Im, Sung-Min Kim, Dajeong Jeong, Kyu Min Lim, Duhee Bang und Dong Soon Lee. „Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics“. Blood 132, Supplement 1 (29.11.2018): 1772. http://dx.doi.org/10.1182/blood-2018-99-118013.
Der volle Inhalt der QuelleMorris, Lindsay Kaye, Matthew Stein, Saradasri Karri, Srishti Sareen, Kruti Patel, Gregory A. Vidal, Lee Steven Schwartzberg und Michael Gary Martin. „Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS).“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): 1080. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1080.
Der volle Inhalt der QuelleKalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev und Rakesh Kumar Tekade. „CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells“. Pharmaceutics 14, Nr. 12 (06.12.2022): 2734. http://dx.doi.org/10.3390/pharmaceutics14122734.
Der volle Inhalt der QuelleSvidnicki, Maria Carolina Costa Melo, Paula De Melo Campos, Moisés Alves Ferreira Filho, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, Hideki Makishima, Seishi Ogawa und Sara T. Olalla Saad. „Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms“. Blood 134, Supplement_1 (13.11.2019): 5395. http://dx.doi.org/10.1182/blood-2019-128764.
Der volle Inhalt der QuelleDameri, Martina, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero und Gabriele Zoppoli. „Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer“. International Journal of Molecular Sciences 22, Nr. 13 (01.07.2021): 7154. http://dx.doi.org/10.3390/ijms22137154.
Der volle Inhalt der QuelleBahman, Fatemah, Valeria Pittalà, Mohamed Haider und Khaled Greish. „Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer“. Journal of Personalized Medicine 11, Nr. 6 (15.06.2021): 559. http://dx.doi.org/10.3390/jpm11060559.
Der volle Inhalt der QuelleHe, W., Y. Zhang, Y. Deng und D. Kabelitz. „Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7.“ Journal of Immunology 154, Nr. 8 (15.04.1995): 3726–31. http://dx.doi.org/10.4049/jimmunol.154.8.3726.
Der volle Inhalt der QuelleBian, Yanlin, Tong Lin, Tanja Jakos, Xiaodong Xiao und Jianwei Zhu. „The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer“. Biomedicines 10, Nr. 8 (30.07.2022): 1843. http://dx.doi.org/10.3390/biomedicines10081843.
Der volle Inhalt der QuelleWang, Nan, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie et al. „Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing“. Chinese Journal of Cancer Research 32, Nr. 2 (2020): 149–62. http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.03.
Der volle Inhalt der QuelleHuang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin et al. „Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Der volle Inhalt der QuelleLanders, Mark, Rhonda Meredith, Jerry Lee, Yipeng Wang, Byung-In Lee und Joseph Monforte. „Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples.“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 1058. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1058.
Der volle Inhalt der QuelleAnders, Carey K., Vandana Abramson, Tira Tan und Rebecca Dent. „The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics“. American Society of Clinical Oncology Educational Book, Nr. 36 (Mai 2016): 34–42. http://dx.doi.org/10.1200/edbk_159135.
Der volle Inhalt der QuelleKhadela, Avinash, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya und Lalitkumar Vora. „Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer“. Cancers 15, Nr. 1 (30.12.2022): 233. http://dx.doi.org/10.3390/cancers15010233.
Der volle Inhalt der QuelleAndreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas und Krisztina Kovacs. „Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells“. International Journal of Molecular Sciences 22, Nr. 4 (19.02.2021): 2056. http://dx.doi.org/10.3390/ijms22042056.
Der volle Inhalt der QuelleShiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih und Chi-Wen Luo. „FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer“. Biomedicines 9, Nr. 12 (29.11.2021): 1789. http://dx.doi.org/10.3390/biomedicines9121789.
Der volle Inhalt der QuelleSubhan, Md Abdus, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide und Valdimir P. Torchilin. „Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type“. Cancers 15, Nr. 8 (08.04.2023): 2204. http://dx.doi.org/10.3390/cancers15082204.
Der volle Inhalt der QuelleJagadish, Nirmala, Sonika Devi, Namita Gupta, Vitusha Suri und Anil Suri. „Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo“. Tumor Biology 42, Nr. 4 (April 2020): 101042832091447. http://dx.doi.org/10.1177/1010428320914477.
Der volle Inhalt der QuelleMohammadhosseinpour, Sepideh, Alexx Weaver, Meenakshi Sudhakaran, Linh-Chi Ho, Tra Le, Andrea I. Doseff und Fabricio Medina-Bolivar. „Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells“. Cancers 15, Nr. 2 (07.01.2023): 399. http://dx.doi.org/10.3390/cancers15020399.
Der volle Inhalt der Quelle